These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33987826)

  • 1. Neurological development of children who are HIV-exposed and uninfected.
    Toledo G; Côté HCF; Adler C; Thorne C; Goetghebuer T
    Dev Med Child Neurol; 2021 Oct; 63(10):1161-1170. PubMed ID: 33987826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
    Ajaykumar A; Zhu M; Kakkar F; Brophy J; Bitnun A; Alimenti A; Soudeyns H; Saberi S; Albert AYK; Money DM; Côté HCF;
    J Infect Dis; 2021 Feb; 223(4):621-631. PubMed ID: 32638023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
    Crowell CS; Williams PL; Yildirim C; Van Dyke RB; Smith R; Chadwick EG; Seage GR; Diperna A; Hazra R;
    AIDS; 2020 Jul; 34(9):1377-1387. PubMed ID: 32310900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
    Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
    Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differences by school-age and adolescence according to in utero and peripartum antiretroviral therapy exposure among Ugandan children.
    Awadu JE; Zalwango SK; Sikorskii A; Giordani B; Bovin MJ; Musoke PM; Ezeamama AE
    Medicine (Baltimore); 2023 Jan; 102(4):e32677. PubMed ID: 36705393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopment of children who are HIV-exposed and uninfected in Kenya.
    Bulterys MA; Njuguna I; King'e M; Chebet D; Moraa H; Gomez L; Onyango A; Malavi K; Nzia G; Chege M; Neary J; Wagner AD; Lawley KA; Wamalwa D; Benki-Nugent S; John-Stewart G
    J Int AIDS Soc; 2023 Oct; 26 Suppl 4(Suppl 4):e26149. PubMed ID: 37909174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.
    Griner R; Williams PL; Read JS; Seage GR; Crain M; Yogev R; Hazra R; Rich K;
    AIDS Patient Care STDS; 2011 Jul; 25(7):385-94. PubMed ID: 21992592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South Africa.
    Springer PE; Slogrove AL; Kidd M; Kalk E; Bettinger JA; Esser MM; Cotton MF; Zunza M; Molteno CD; Kruger M
    AIDS Care; 2020 Apr; 32(4):411-419. PubMed ID: 31280587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early child development in children who are HIV-exposed uninfected compared to children who are HIV-unexposed: observational sub-study of a cluster-randomized trial in rural Zimbabwe.
    Ntozini R; Chandna J; Evans C; Chasekwa B; Majo FD; Kandawasvika G; Tavengwa NV; Mutasa B; Mutasa K; Moulton LH; Humphrey JH; Gladstone MJ; Prendergast AJ;
    J Int AIDS Soc; 2020 May; 23(5):e25456. PubMed ID: 32386127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children.
    Yao TJ; Malee K; Zhang J; Smith R; Redmond S; Rice ML; Frederick T; Torre P; Mellins CA; Hoffman HJ; Williams PL
    AIDS Patient Care STDS; 2023 Mar; 37(3):119-130. PubMed ID: 36827595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopment among children exposed to HIV and uninfected in sub-Saharan Africa.
    Bulterys MA; Njuguna I; Mahy M; Gulaid LA; Powis KM; Wedderburn CJ; John-Stewart G
    J Int AIDS Soc; 2023 Oct; 26 Suppl 4(Suppl 4):e26159. PubMed ID: 37909232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
    Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
    Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Language outcomes of preschool children who are HIV-exposed uninfected: An analysis of a South African cohort.
    Green F; du Plooy C; Rehman AM; Nhapi RT; Lake MT; Barnett W; Hoffman N; Zar HJ; Donald KA; Stein DJ; Wedderburn CJ
    PLoS One; 2024; 19(4):e0297471. PubMed ID: 38598467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
    Piske M; Budd MA; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen P; Côté HCF;
    AIDS; 2018 Nov; 32(17):2583-2592. PubMed ID: 30134292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children.
    El Beitune P; Duarte G; Quintana SM; Figueiró-Filho EA; Marcolin AC; Abduch R
    Braz J Infect Dis; 2004 Apr; 8(2):140-50. PubMed ID: 15361992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study.
    Wedderburn CJ; Yeung S; Rehman AM; Stadler JAM; Nhapi RT; Barnett W; Myer L; Gibb DM; Zar HJ; Stein DJ; Donald KA
    Lancet Child Adolesc Health; 2019 Nov; 3(11):803-813. PubMed ID: 31515160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.